European Globe: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on European Globe.

Press releases published on October 1, 2026

Oct. 1, 2026

รายงานจาก Templafy ชี้แรงงานสายความรู้ 95% ต้องแก้ไขเอกสารที่จัดทำโดย AI…

Indeterminate GlobeNewswire

Oct. 1, 2026

Templafy 报告发现：95% 的知识工作者在 AI 生成文档达到商用标准前仍需手动编辑

Indeterminate GlobeNewswire

Oct. 1, 2026

Templafy 報告發現，95% 的知識工作者在 AI 生成文件準備好用於業務前會先行編輯

Indeterminate GlobeNewswire

Oct. 1, 2026

One Bullion Completes Second Hole of 2026 Drilling Program at Vumba Gold Project

Indeterminate GlobeNewswire

Oct. 1, 2026

Maxus Mining Completes Inaugural Drill Program at Alturas West, Intersecting Visible Antimony Mineralization in 9 of 11 Holes

Indeterminate GlobeNewswire

Oct. 1, 2026

Dynacor Appoints New Chief Operating Officer

Indeterminate GlobeNewswire

Oct. 1, 2026

Dynacor nomme un nouveau chef des opérations

Indeterminate GlobeNewswire

Oct. 1, 2026

DEEP SEA MINERALS CORP. WELCOMES CONTINUED U.S. EFFORTS TO MAP OFFSHORE CRITICAL MINERAL RESOURCES

Indeterminate GlobeNewswire

Oct. 1, 2026

InflaRx Appoints Gabriela Alperovich, MD, PhD, as Senior Vice President & Global Head of Clinical Development

Indeterminate GlobeNewswire

Oct. 1, 2026

DPM Metals Announces Constitutional Court of Bosnia and Herzegovina Decision

Indeterminate GlobeNewswire

Oct. 1, 2026

Big Bear Gold Corp. Signs Assignment and Assumption of Property Option Agreement to Acquire 100% Optioned Interest in Peerless Property

Indeterminate GlobeNewswire

Oct. 1, 2026

Pirate Gold Announces up to $15 Million Brokered Flow-Through Private Placement

Indeterminate GlobeNewswire

Oct. 1, 2026

Templafy Report Finds 95% of Knowledge Workers Edit AI-Generated Documents Before They’re Business-Ready

Indeterminate GlobeNewswire

Oct. 1, 2026

MitoRx Therapeutics presents new preclinical data on MTRX31, demonstrating restored mitochondrial density, at the 62nd EASD Annual Meeting

Indeterminate GlobeNewswire

Oct. 1, 2026

Ocular Therapeutix™ to Participate in October Scientific and Investor Conferences

Indeterminate GlobeNewswire

Oct. 1, 2026

Foghorn Therapeutics Provides Update on FHD-909 and Strategic Priorities

Indeterminate GlobeNewswire

Oct. 1, 2026

Fate Therapeutics to Participate in Upcoming Fourth Quarter 2026 Conferences

Indeterminate GlobeNewswire

Oct. 1, 2026

Kailera Therapeutics Presents New Clinical Data at EASD 2026 Annual Meeting

Indeterminate GlobeNewswire

Oct. 1, 2026

Costamare Inc. Declares Quarterly Dividend on Its Preferred and Common Stock

Indeterminate GlobeNewswire

Oct. 1, 2026

Agomab Reports Positive Topline Data from STENOVA Open-Label Extension Study of Ontunisertib in Fibrostenosing Crohn's Disease

Indeterminate GlobeNewswire